Press releases

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Feb 2022
18:13 E.S.T.

Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST

Feb 2022
20:22 E.S.T.

Calyxt Announces Pricing of Offering of Common Stock and Warrants and Updates Business and Risk Factor Disclosure

Feb 2022
21:44 E.S.T.

Cellectis Appoints Bing Wang, PhD, MBA as Chief Financial Officer

Jan 2022
21:30 E.S.T.

Cellectis’ Licensed Partner, Allogene Therapeutics, Announces Removal of FDA Clinical Hold on their Clinical Trials

Jan 2022
19:37 E.S.T.

Cellectis Provides Business Objectives for 2022 and Updates its Corporate Presentation

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team